Last viewed:
CYCN
Prices are updated after-hours
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
(0.0% 1d)
(9.4% 1m)
(-41.3% 1y)
(0.0% 2d)
(0.0% 3d)
(5.4% 7d)
(526.19%
volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 8,983,968
http://www.cyclerion.com
Sec
Filling
|
Patents
| 94 employees
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
treatment
add to watch list
Paper trade
email alert is off
Press-releases
Cyclerion Appoints Regina Graul, Ph.D., as President
Published: 2023-12-04
(Crawled : 13:00)
- globenewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
| -55.64%
| O: 3.23%
H: 0.0%
C: 0.0%
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| 40.75%
| O: -4.29%
H: 5.67%
C: -4.62%
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
Published: 2023-11-30
(Crawled : 08:00)
- globenewswire.com
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| 60.55%
| O: 6.88%
H: 40.77%
C: 6.72%
company
builder
Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets
Published: 2023-07-31
(Crawled : 11:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -10.78%
| O: 3.56%
H: 0.0%
C: 0.0%
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| 25.0%
| O: 1.08%
H: 12.94%
C: 12.94%
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors
Published: 2023-06-13
(Crawled : 11:00)
- investor.alkermes.com
ENDPQ
|
$0.0006
-50.0%
3.4K
|
n/a
| -92.45%
| O: -47.17%
H: 110.71%
C: 96.43%
IRM
|
$75.1
0.91%
-0.07%
1.1M
|
Finance
| 33.23%
| O: -0.18%
H: 0.94%
C: 0.2%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
| 63.1%
| O: -0.37%
H: 0.84%
C: 0.46%
AMRX
|
$5.42
1.12%
1.11%
1.1M
|
Health Technology
| 115.08%
| O: 0.4%
H: 8.7%
C: 1.98%
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
| -49.08%
| O: 0.94%
H: 0.0%
C: -0.93%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
| 15.76%
| O: 0.08%
H: 1.04%
C: 0.36%
UTHR
|
$237.99
0.45%
0.45%
400K
|
Health Technology
| 4.4%
| O: -0.65%
H: 2.13%
C: 1.37%
RARE
|
News
F
|
$42.37
-2.33%
-2.38%
680K
|
Health Technology
| -17.57%
| O: 0.72%
H: 2.22%
C: 0.5%
SRPT
|
$115.53
-0.88%
-0.9%
640K
|
Health Technology
| -11.11%
| O: 0.55%
H: 2.23%
C: -0.71%
SAGE
|
$13.35
2.42%
2.36%
1.3M
|
Health Technology
| -76.88%
| O: 0.07%
H: 2.89%
C: 1.85%
PTCT
|
News
S
|
$25.32
2.55%
2.49%
3.9M
|
Health Technology
| -41.59%
| O: -0.3%
H: 2.48%
C: 1.97%
PRTA
4
|
$21.17
2.92%
2.83%
510K
|
Health Technology
| -71.02%
| O: 0.29%
H: 5.34%
C: 4.38%
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
| 41.19%
| O: 0.05%
H: 2.35%
C: 2.29%
MDXG
|
$6.3
2.27%
2.22%
690K
|
Health Technology
| 6.61%
| O: 0.85%
H: 1.34%
C: -0.17%
LPTX
|
$2.81
-5.07%
-5.34%
200K
|
Health Technology
| -57.88%
| O: 0.0%
H: 9.63%
C: 9.63%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
| -12.48%
| O: -0.02%
H: 1.93%
C: 1.16%
IRWD
|
$7.94
4.47%
4.28%
2.5M
|
Health Technology
| -30.65%
| O: 0.0%
H: 0.35%
C: -3.42%
IONS
|
$40.64
-0.42%
-0.42%
850K
|
Health Technology
| -2.28%
| O: 0.17%
H: 1.25%
C: 0.46%
INFI
|
$0.016
12.5%
1.1M
|
Health Technology
| -91.05%
| O: 0.0%
H: 0.0%
C: -5.76%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
| -15.7%
| O: -0.48%
H: 1.44%
C: 0.24%
IDXX
|
$476.29
-0.31%
-0.31%
570K
|
Health Technology
| 3.45%
| O: 0.31%
H: 1.9%
C: 1.42%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
| 17.97%
| O: 0.05%
H: 0.89%
C: 0.52%
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| -19.54%
| O: 6.44%
H: 0.41%
C: -1.94%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
| 50.7%
| O: 0.62%
H: 2.47%
C: 0.53%
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 1377.42%
| O: -1.06%
H: 6.94%
C: -2.15%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
| -25.21%
| O: 0.07%
H: 2.64%
C: 2.23%
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
| -23.61%
| O: 0.19%
H: 1.58%
C: 0.64%
ACAD
|
$16.82
-1.47%
-1.49%
3.5M
|
Health Technology
| -31.65%
| O: 0.12%
H: 1.83%
C: 1.58%
IBIO
|
$1.72
-2.83%
0.0%
95K
|
Health Technology
| 136.1%
| O: 16.68%
H: 3.53%
C: -11.59%
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement
Published: 2023-06-01
(Crawled : 20:00)
- ir.cyclerion.com
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| -19.54%
| O: 1.61%
H: 6.11%
C: -1.58%
nasdaq
Cyclerion Announces Reverse Stock Split
Published: 2023-05-15
(Crawled : 17:00)
- globenewswire.com
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| -21.59%
| O: 3.0%
H: 8.19%
C: -16.83%
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
Published: 2023-05-11
(Crawled : 21:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -14.18%
| O: 0.26%
H: 0.0%
C: 0.0%
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| -41.28%
| O: -4.56%
H: 1.9%
C: -21.52%
cy3018
agreement
Cyclerion Announces Corporate Updates and Q1 2023 Financial Results
Published: 2023-05-11
(Crawled : 21:00)
- globenewswire.com
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| -41.28%
| O: -4.56%
H: 1.9%
C: -21.52%
AKBA
|
$1.36
-2.16%
-2.21%
2.9M
|
Health Technology
| 28.3%
| O: 0.94%
H: 9.35%
C: 5.61%
financial
results
Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement
Published: 2023-04-03
(Crawled : 12:00)
- ir.cyclerion.com
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| -59.67%
| O: -2.49%
H: 2.34%
C: -15.88%
therapeutics
agreement
Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases
Published: 2023-03-27
(Crawled : 11:00)
- ir.cyclerion.com
CYCN
|
$3.315
12.62%
3.3K
|
Health Technology
| -59.91%
| O: 21.42%
H: 13.55%
C: 1.89%
fda
drug
treatment
designation
therapeutics
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0000899243-23-018047
4
2023-08-11
2023-08-09
Sell
S
8
0